Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
September 16, 2019
Bellerophon Receives Orphan Drug Designation for Nitric Oxide in the Treatment of Idiopathic Pulmonary Fibrosis
WARREN, N.J., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, announced today the U.S. Food ...
September 16, 2019
Cellectar Presents Data from Cohort 6 of its CLR 131 Phase 1 Study in Patients with Relapsed or Refractory Multiple Myeloma
FLORHAM PARK, N.J., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs ...
September 16, 2019
Neovasc Announces Changes to its Board of Directors
VANCOUVER, Sept. 16, 2019 /PRNewswire/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral ...
September 16, 2019
Establishment Labs Receives Notice of Allowance for Key U.S. Patent Application Covering Company’s Implant Surface Technology and Announces 510(k) Submission for its Tissue Expander
NEW YORK, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (ESTA), a medical technology company focused on women’s health, initially in the breast ...
September 16, 2019
Pluristem Therapeutics Recaps Key Opinion Leader Call Reviewing Hematological Programs
HAIFA, Israel, Sept. 16, 2019 (GLOBE NEWSWIRE) -- PluristemTherapeutics Inc. (PSTI) (PSTI), a leading regenerative medicine company developing novel placenta-based cell therapy products, today provided ...
September 16, 2019
Celyad Announces Closing of $20 Million Global Offering
MONT-SAINT-GUIBERT, Belgium, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of ...
September 16, 2019
Cidara Therapeutics to Participate in Two Upcoming Investor Conferences
SAN DIEGO, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that Paul Daruwala, ...
September 16, 2019
Pfenex to Present at the Cantor Healthcare Conference
SAN DIEGO, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex ...
September 11, 2019
Zealand Pharma completes subscription of new shares and registration of capital increase
Copenhagen, September 11, 2019 – With reference to the company announcement no. 30/2019 dated September 5, 2019 regarding a private placement and directed issue of ...
September 11, 2019
Athenex Announces Initiation of Phase I Clinical Study in China of KX2-361 Oral by Partner Guangzhou Xiangxue Pharmaceutical
BUFFALO, N.Y., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies ...
September 11, 2019
Outlook Therapeutics to Present at the 29th Annual Ladenburg Thalmann 2019 Healthcare Conference
CRANBURY, N.J., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (OTLK) (the “Company”) today announced that it is scheduled to participate in the Ladenburg ...
September 10, 2019
Santhera Announces Publication of Phase I Clinical Data with POL6014 in Journal of Cystic Fibrosis
Pratteln, Switzerland, September 10, 2019 – Santhera Pharmaceuticals (SANN.SW) announces the online publication of Phase I data with its human neutrophil elastase (hNE) inhibitor POL6014 in ...
September 10, 2019
Kiadis Pharma announces results for the six months ended June 30, 2019
Amsterdam, The Netherlands, September 10, 2019 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical-stage biopharmaceutical company, today announces ...
September 10, 2019
ASIT biotech Conference Calendar H2 2019
ASIT biotech (ASIT.BR) (ASIT.BR) (ASIT - BE0974289218), a clinical stage biopharmaceutical company focused on the research, development and future commercialization of breakthrough allergy immunotherapy products, ...
September 10, 2019
iCAD’s ProFound AI Reader Study Published in Radiology: Artificial Intelligence
NASHUA, N.H., Sept. 10, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the ...
September 10, 2019
Cellectar Announces Oral Presentation at the European Society for Medical Oncology (ESMO) Congress 2019
FLORHAM PARK, N.J., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs ...
September 10, 2019
STRATA Skin Sciences to Participate in Ladenburg Thalmann 2019 Healthcare Conference
HORSHAM, Pa., Sept. 10, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, ...
September 10, 2019
UroGen To Host Investor Day on September 24, 2019 Spotlighting Clinical Development Updates and UGN-101 Launch Readiness
UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in uro-oncology, today announced that it will host an Investor Day ...
September 10, 2019
Catalyst Psychiatry Now Offering Mental Health Technology for Patients with Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD) in Corvallis
CORVALLIS, Ore., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Catalyst Psychiatry, a provider of mental health services in Oregon, is now offering BrainsWay’s Deep Transcranial Magnetic ...
September 10, 2019
Inventiva announces the positive recommendation of the 4th and last DSMB of the Phase IIb clinical study with lanifibranor in NASH
Daix (France), September 10, 2019 – Inventiva (IVA.NX), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of diseases in the areas ...
Page 9 of 169